Cannabis firm Rua Bioscience targets October NZX listing

Cannabis firm Rua Bioscience targets October NZX listing
Brent Melville
Medicinal cannabis firm Rua Bioscience has signalled it will head to the NZX this October, breaking an initial public offering drought that has persisted since Napier Port listed in August last year.Chair Trevor Burt said the East Coast-based cannabis company, one of the first in New Zealand to be licensed for commercial production, is aiming for an IPO in the latter part of the year, “subject to market conditions and other company developments.”He said while the number of shares and price range are “yet to be decided,&rd...

More Markets

NZ sharemarket continues sliding, down 0.5%
Markets Market close

NZ sharemarket continues sliding, down 0.5%

The S&P/NZX 50 Index closed at 12,692.72, down 68.47 points or 0.54%.

Spark sells remaining Connexa stake for $314m
Markets

Spark sells remaining Connexa stake for $314m

The sale will result in a $70m gain on telco's books.

Ben Moore 11:45am
Zespri on track for 'moderate increase' in volume next year
Primary Sector

Zespri on track for 'moderate increase' in volume next year

Zespri's producer vote to expand global supply passed this week.

Neal Barclay to exit Meridian as CEO
Markets

Neal Barclay to exit Meridian as CEO

Current CFO Mike Roan will take Barclay's spot atop Meridian.